The Genomic Power Shift is not only a book. It is also a platform for helping organisations understand what happens when genomics, artificial intelligence, biotechnology and society begin to converge.
Through speaking, media work, investment support, strategic consultancy and executive education, the project helps leaders make sense of one of the most important technological shifts of our time: the moment when the language of life becomes readable, programmable, investable and politically consequential.
Press and media enquiries for informed, accessible commentary on genomics, artificial intelligence, biotechnology, ethics and society.
View press & media enquiries →Public SpeakingKeynotes, panels and talks about genomics, AI, biotechnology, precision medicine, biosecurity, ethics and the future of biology.
Explore speaking topics →Venture CapitalTechnical, scientific and strategic support for investors evaluating genomics, biotech, synthetic biology and AI-driven life-science companies.
Explore investor support →Strategy ConsultancyStrategic guidance for organisations navigating genomics, AI, biotechnology, precision medicine, data, regulation and emerging markets.
Explore strategy support →Executive BriefingsPrivate executive briefings on genomics, AI and biotechnology for boards, leadership teams, investors and decision-makers.
Book a briefing →WorkshopsTailored workshops about genomics, AI, biotechnology, ethics, regulation and future scenarios for teams and organisations.
Explore workshops →Advisory RolesBoard, strategic and expert advisory support across genomics, biotechnology, AI, health, food, biodiversity, ethics and society.
Discuss advisory work →Interested in working together?
For speaking, media, investment, strategy or advisory enquiries, get in touch.